135949-89-2

Upstream product

• 141437-86-7 [(S)-2-Phenyl-1-(pyridin-2-yldisulfanylmethyl)-ethyl]-carbamic acid tert-butyl ester 
• 81110-69-2 N-(2-mercaptomethyl-3-phenyl-1-oxopropyl)-glycine benzyl ester 
• 141437-85-6 (S)-tert-butyl (1-mercapto-3-phenylpropan-2-yl)carbamate 
• 122818-32-0 (S)-2-<(tert-Butoxycarbonyl)amino>-3-phenylpropyl thioacetate 
• 141437-88-9 {2-[2-(Benzyloxycarbonylmethyl-carbamoyl)-3-phenyl-propyldisulfanylmethyl]-3-phenyl-propionylamino}-acetic acid benzyl ester 
• 141437-87-8 2-(2-Carboxy-3-phenyl-propyldisulfanylmethyl)-3-phenyl-propionic acid 

Downstream Products

• 135949-57-4 [2-((S)-2-Amino-3-phenyl-propyldisulfanylmethyl)-3-phenyl-propionylamino]-acetic acid benzyl ester 

Relevant academic research and scientific papers

"Mixed Inhibitor-Prodrug" as a New Approach toward Systemically Active Inhibitors of Enkephalin-Degrading Enzymes

In order to evaluate the possible advantages of potentiating the effects of the endogenous enkephalins, to obtain analgesia without the serious drawbacks of morphine, it was essential to design systemically active compounds which inhibit the two metaboliz